2017 Annual Meeting

049 - SESSION 49: Antibodies and Other Determinants of Cardiac Rejection: Let's ROCK and Rho

Apr 8, 2017 12:00pm ‐ Apr 8, 2017 1:30pm


Description

(509) The Incidence of Donor-Specific Antibody in the Presence of Biopsy-Proven Antibody-Mediated Rejection After Heart Transplantation
Sean Sana, MD

(510) Longitudinal Rho-Associated Kinase (ROCK) Activity Correlates with Rejection in Heart Transplant Recipients
Bow Chung, MD

(511) Pre-Transplant Donor-Recipient Characteristics and the Relationship to Early Cardiac Allograft Injury Measured by Cell-Free DNA
Palak Shah, MD, MS

(512) Identification and Validation of Non-HLA Antibodies in Cardiac Allograft Rejection
Carrie Butler, PhD

(513) Combined Heart and Liver Transplantation in Highly Sensitized Patients: Protection of the Cardiac Allograft from Antibody Mediated Rejection by Initial Liver Implantation
Richard Daly, MD

(514) Racial Differences in the Development of De Novo DSA andTreated AMR Following Heart Transplantation
Robert Cole, MD

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content